The potential insights of Traditional Chinese Medicine on treatment of COVID-19

被引：0
作者：
Tong Tong
Ying-Qi Wu
Wei-Jian Ni
Ai-Zong Shen
Sheng Liu
机构：
[1] University of Science and Technology of China,Department of Pharmacy, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine
来源：
Chinese Medicine | / 15卷
关键词：
Traditional Chinese medicine; SARS-CoV-2; COVID-19; Treatment; Mechanism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Corona Virus Disease 2019 (COVID-19) broke out in 2019 and spread rapidly around the world. There is still no specific antiviral therapy to the current pandemic. In China, historical records show that Traditional Chinese Medicine (TCM) is effective in prevention and enhancing the resistance to pandemic with unique insights. To fight with COVID-19, National Health and Commission of PRC has recommended some TCM in the guideline, such as HuoxiangZhengqi, LianhuaQingwen ShufengJiedu and XueBijing, and actually displayed a remarkable effect in clinical treatment strategic for COVID-19. We review studies to provide an in-depth understanding into the effect of TCM, and also introduce the possible mechanism involved in COVID-19 treatment.
引用
收藏
相关论文
共 122 条
[1]  
Huang C(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet. 395 497-506
[2]  
Wang Y(2004)Clinical observation on treatment of SARS with combination of chaihu droplet pill and huoxiangzhengqi droplet pill Zhongguo Zhong Xi Yi Jie He Za Zhi. 24 321-324
[3]  
Li X(2020)Clinical features and treatment of 2019-nCov pneumonia patients in Wuhan: report of a couple cases Virol Sin. 8 420-422
[4]  
Ren L(2020)Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lancet Respir Med. 12 7346-7349
[5]  
Zhao J(2006)Effects of huoxiangzhengqi liquid on enteric mucosal immune responses in mice with Bacillus dysenteriae and Salmonella typhimurium induced diarrhea World J Gastroenterol 51 1113-1122
[6]  
Hu Y(2020)Study on active compounds from Huoxiang Zhengqi Oral Liquid for prevention of coronavirus disease 2019 (COVID-19) based on network pharmacology and molecular docking Chin Tradit Herbal Drugs. 15 150-154
[7]  
Li H(2020)Clinical effectiveness and case analysis in 54 NCP patients treated with Lianhuaqingwen granules World Chin Med. 51 1723-1730
[8]  
Lu CZ(2020)Exploring material basis and mechanism of Lianhua Qingwen prescription against coronavirus based on network pharmacology Chin Tradit Herbal Drugs. 41 102311-158
[9]  
Tang KC(2020)The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality Int J Antimicrob Agents 28 153-350
[10]  
Zhang Z(2020)Efficacy of lianhuaqingwen granules in the management of chronic rhinosinusitis without nasal polyps Am J Otolaryngol 32 347-68
12345678910